Arglabin is primarily used in the field of oncology due to its potent antitumor properties. It functions as a sesquiterpene lactone, which helps inhibit the growth of cancer cells by inducing apoptosis (programmed cell death) and blocking angiogenesis (formation of new blood vessels that supply tumors). This makes it a promising candidate for the development of cancer therapies, particularly in cases where traditional treatments are less effective. Additionally, Arglabin has shown potential in enhancing the efficacy of chemotherapy drugs when used in combination therapies. Its ability to modulate the immune system further supports its role in cancer treatment, making it a valuable compound in ongoing medical research.